. Author manuscript; available in PMC: 2014 Jun 15.

Published in final edited form as: Cancer Res. 2013 Oct 11;73(24):7162–7167. doi: 10.1158/0008-5472.CAN-13-2498

Table 3.

Correlation between TERT promoter mutation status and tumor recurrence.

	Recurrence on follow-up	Number of patients	TERT mutation present (%)	TERT mutation absent (%)	P
pTa LG (N =28)^a	Yes	17	16/17 (94%)	1/17 (6.0%)	0.21
pTa LG (N =28)^a	No	9	7/9 (78%)	2/9 (22%)
pTa HG (N =31)^a	Yes	17	13/17 (77%)	4/17 (24%)	0.14
pTa HG (N =31)^a	No	12	6/12 (50%)	6/12 (50%)
CIS (N =17)	Yes	11	7/11 (64%)	4/11 (36%)	0.90
CIS (N =17)	No	6	4/6 (67%)	2/6 (33%)

Recurrence status was not available in two cases. CIS: Carcinoma in situ; HG: high-grade noninvasive urothelial carcinoma; LG: low-grade noninvasive urothelial carcinoma.